Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06566703 · ClinicalTrials.gov registry record · NA
Testing ANSOS for Efficacy in Multi-Tribal Urban Communities
A NA study of Smokeless Tobacco Cessation, sponsored by Lehigh University.
- Recruiting
- Registry status
- NA
- Development phase
- 384
- Enrollment target
- 1
- Study location
NCT06566703: Recruiting NA study of Smokeless Tobacco Cessation, sponsored by Lehigh University.
NCT06566703 is a NA study of Smokeless Tobacco Cessation that is actively recruiting participants, run by Lehigh University. The registered enrollment target is 384 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (73% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06566703, a NA study of Smokeless Tobacco Cessation, is actively recruiting participants, sponsored by Lehigh University.
- RECRUITING
- Registry status
- NA
- Development phase
- 384 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a wait-list control trial to test for efficacy of the All Nations Snuff Out Smokeless (ANSOS) recreational tobacco cessation program in multi-tribal American Indian (AI) communities. Participants randomized to the control arm are provided with a Healthy Living educational intervention while they wait for the program to encourage them to remain engaged with the study team during the six-month waiting period. Participants from the ANSOS arm are offered the Healthy Living educational intervention after they complete the 6-month outcome measures.
Primary Outcome
7-day point prevalence abstinence from smokeless tobacco product use
Conditions Studied
Interventions
- BEHAVIORAL All Nations Snuff Out Smokeless
- BEHAVIORAL Healthy Living
Study Locations (1)
Pennsylvania
- Lehigh University - Bethlehem
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 384 participants |
| Start Date | 2023-08-18 |
| Est. Completion | 2026-08-18 |
| Phase | NA |
What NCT06566703 shows while recruiting
NCT06566703 is an interventional study that assigns participants to a tested intervention. The registered 384 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (73% lower).
The record links to 1 condition, with Smokeless Tobacco Cessation appearing as the primary indexed condition, and to 2 interventions - of which All Nations Snuff Out Smokeless is the first listed.
NCT06566703 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT06566703 about?
NCT06566703 is a clinical study titled "Testing ANSOS for Efficacy in Multi-Tribal Urban Communities". This is a wait-list control trial to test for efficacy of the All Nations Snuff Out Smokeless (ANSOS) recreational tobacco cessation program in multi-tribal American Indian (AI) communities. Participants randomized to the control arm are provided with a Healthy Living educational intervention while ...
What is the current status of trial NCT06566703?
This trial is currently recruiting. It is a NA study. The enrollment target is 384 participants. The study started on 2023-08-18. Estimated completion is 2026-08-18.
What conditions does trial NCT06566703 study?
This clinical trial studies the following conditions: Smokeless Tobacco Cessation.
What interventions are being tested in trial NCT06566703?
The interventions under investigation include: All Nations Snuff Out Smokeless (BEHAVIORAL), Healthy Living (BEHAVIORAL).
Who is sponsoring clinical trial NCT06566703?
This trial is sponsored by Lehigh University, which has 12 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06566703 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06566703's enrollment target sits among peer trials
384 271st of 2000 higher than 1,728 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06277661 · 384 participants · NA
The Mom and Infant Outcomes (MOMI) Study
- NCT06372964 · 384 participants · Phase 3
Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients
- NCT06501040 · 384 participants · NA
Increasing Knowledge and Interest in Cancer Clinical Trials
- NCT06968650 · 384 participants · NA
Cocooned Moms Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI